X-energy Stock Rises 15.1% to $21.40
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 15 2026
0mins
X-energy is up 15.1%, or $2.81 to $21.40.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy XE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on XE
Wall Street analysts forecast XE stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 18.480
Low
Averages
High
Current: 18.480
Low
Averages
High
About XE
X-Energy, Inc. is a designer of advanced nuclear reactor technology and manufacturer of advanced nuclear fuels. The Company’s flagship product, the Xe-100, an advanced small modular high-temperature gas-cooled reactor (HTGR), in development for nearly a decade. The Xe-100 reactor is designed to generate 80 megawatts of electric power or 200 megawatts of thermal output (heat), or a combination thereof. The Xe-100 has several technological attributes, such as advanced safety features, virtually no direct GHG emissions during generation, high thermal output, load-following capabilities and modularity, all of which allow it to more specifically meet a customer’s power and/or industrial heat needs. Its Xe-100 design directly translates into simplicity of project delivery through reduced supply chain complexity and labor intensity during construction, which lead to lower costs and faster deployment timelines when compared with conventional nuclear energy sources.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
X-Energy Shares Plunge 19% Due to Delays and Downgrade
- Significant Stock Decline: X-Energy's shares fell 19% this week, bringing its market cap to $7.5 billion, reflecting investor concerns about its future amid ongoing challenges since its April IPO.
- Project Delays Impact: The lack of U.S. government approval for X-Energy's reactor designs has delayed the groundbreaking of its first project with Amazon until 2027, directly affecting the company's business outlook.
- Analyst Downgrade: Jeffries downgraded X-Energy's stock from $30 to $22, exacerbating investor panic and leading to a sharp decline in share prices.
- Lack of Actual Business: Despite a market cap of $7.7 billion, X-Energy has minimal revenue, prompting investors to carefully consider whether to buy the stock under current circumstances.
See More
X-Energy Reactor Design Lacks Approval, Shares Plummet
- Project Delays Impact: X-Energy's reactor design lacks official approval from the U.S. government, causing delays in its first project with Amazon until 2027, which negatively affects the company's growth prospects and investor confidence.
- Analyst Downgrade: Jefferies downgraded X-Energy's stock from $30 to $22, resulting in a 19% drop in shares this week, reflecting market concerns about its future profitability.
- Poor Revenue Situation: Despite a market cap of $7.7 billion, X-Energy currently generates almost no revenue, indicating the fragility of its business model and potentially leading investors to be cautious about future returns.
- Massive Funding Needs: To secure reactor design approvals and establish manufacturing facilities, X-Energy will require substantial upfront capital, which will further strain its finances and limit its competitiveness in the nuclear energy market.
See More
Jefferies Reports Doubling of Profit in Q2 Amid Strong Investment Banking Trends
- Profit Surge: Jefferies reported a profit of $226.2 million in Q2, translating to $1.02 per share, a significant increase from $88 million or $0.40 per share a year ago, indicating robust performance in investment banking.
- Advisory Revenue Boom: Advisory revenue surged 47% to a record $674.1 million, while investment banking net revenues jumped 57.5% year-over-year to $1.21 billion, reflecting strong demand for M&A advisory services in the current market.
- Equity Market Activity: Equity underwriting revenue exceeded $370.7 million in the quarter, more than tripling year-over-year, with Jefferies acting as joint global coordinator on Galderma's $6.3 billion share sale, marking the largest sponsor-backed block trade in history.
- Trading Revenue Growth: Jefferies' capital markets business posted $799.3 million in revenue, up 13.5% from last year, with equities trading revenue rising 14% to a record $600.8 million, highlighting a trend of investors adjusting portfolios amid market volatility.
See More
SpaceX's Historic IPO Drives Record 2Q Market Recovery
- Market Recovery: The IPO market rebounded quickly in Q2, with 48 companies going public and raising a record $104.9 billion, indicating a resurgence of market confidence.
- SpaceX's Major Deal: SpaceX raised $75 billion in its IPO, surpassing the total of all US IPOs from the previous two years combined, achieving a market cap of $1.7 trillion at listing, making it one of the largest public companies on US exchanges.
- Strong First Day Performance: SpaceX's stock rose 19% on its debut, alleviating concerns about an overly hot or cold opening, although aftermarket trading remained volatile.
- Large Deal Momentum: Even without SpaceX's deal, Q2 would have been the largest quarter for IPO proceeds since 2021, with nine other IPOs raising over $1 billion, showcasing the ongoing appeal of large transactions.
See More
X-Energy Reports Strong First Earnings as Public Company
- First Earnings Highlights: X-Energy reported $43 million in revenue and grant income in its first FQ1 2026 earnings release as a public company, indicating strong market demand and growth potential.
- Successful IPO Financing: The company raised approximately $1.1 billion through its IPO on the Nasdaq Global Select Market, providing ample funding for future R&D and market expansion, thereby enhancing its financial stability.
- Significant Regulatory Progress: X-Energy made strides in regulatory and commercialization efforts, achieving progress in the UK Generic Design Assessment process and obtaining environmental clearance from the US Nuclear Regulatory Commission for a Texas project, marking a crucial step towards commercializing its small modular reactor technology.
- Strengthened Supply Chain Collaborations: The company has established agreements with industrial partners like SGL Carbon and IHI Corporation, and is engaging in exploratory deployment discussions with US energy utilities in Kentucky and Pennsylvania, further solidifying its supply chain and deployment pipeline.
See More
CHWY, XE, and WIX Stocks Hit Annual Lows Amid Weak Outlook
- CHWY Stock Decline: Chewy Inc.'s shares fell to an annual low of $19.08, down over 56% from its yearly high, as management flagged increasing challenges in the consumer pet environment despite reporting revenue and earnings growth in Q1, leading to price target cuts from Wall Street analysts that impacted investor confidence.
- XE Faces Financial Pressure: X-energy Inc.'s stock dropped to $18, marking a new low since its public listing, as retail investors turned bearish amid financial, valuation, and execution concerns, despite raising over $1 billion in a record nuclear IPO in April, resulting in a more than 38% decline since debut.
- WIX Hits 52-Week Low: Wix.com shares slumped to $46.10, influenced by Wall Street analysts' concerns over its growth outlook amid AI pressures, and the company revised its 2026 revenue expectations downward following workforce reductions, prompting multiple firms to cut price targets.
- Analysts Lower Price Targets: Major firms like Morgan Stanley, BofA, and UBS have reduced price targets for CHWY and WIX, reflecting market concerns about future growth, although retail investors remain optimistic about the fundamentals of these companies, indicating a divergence in market sentiment.
See More
X-Energy Shares Plunge 19% Due to Delays and Downgrade
- Significant Stock Decline: X-Energy's shares fell 19% this week, bringing its market cap to $7.5 billion, reflecting investor concerns about its future amid ongoing challenges since its April IPO.
- Project Delays Impact: The lack of U.S. government approval for X-Energy's reactor designs has delayed the groundbreaking of its first project with Amazon until 2027, directly affecting the company's business outlook.
- Analyst Downgrade: Jeffries downgraded X-Energy's stock from $30 to $22, exacerbating investor panic and leading to a sharp decline in share prices.
- Lack of Actual Business: Despite a market cap of $7.7 billion, X-Energy has minimal revenue, prompting investors to carefully consider whether to buy the stock under current circumstances.
See More
X-Energy Reactor Design Lacks Approval, Shares Plummet
- Project Delays Impact: X-Energy's reactor design lacks official approval from the U.S. government, causing delays in its first project with Amazon until 2027, which negatively affects the company's growth prospects and investor confidence.
- Analyst Downgrade: Jefferies downgraded X-Energy's stock from $30 to $22, resulting in a 19% drop in shares this week, reflecting market concerns about its future profitability.
- Poor Revenue Situation: Despite a market cap of $7.7 billion, X-Energy currently generates almost no revenue, indicating the fragility of its business model and potentially leading investors to be cautious about future returns.
- Massive Funding Needs: To secure reactor design approvals and establish manufacturing facilities, X-Energy will require substantial upfront capital, which will further strain its finances and limit its competitiveness in the nuclear energy market.
See More
Jefferies Reports Doubling of Profit in Q2 Amid Strong Investment Banking Trends
- Profit Surge: Jefferies reported a profit of $226.2 million in Q2, translating to $1.02 per share, a significant increase from $88 million or $0.40 per share a year ago, indicating robust performance in investment banking.
- Advisory Revenue Boom: Advisory revenue surged 47% to a record $674.1 million, while investment banking net revenues jumped 57.5% year-over-year to $1.21 billion, reflecting strong demand for M&A advisory services in the current market.
- Equity Market Activity: Equity underwriting revenue exceeded $370.7 million in the quarter, more than tripling year-over-year, with Jefferies acting as joint global coordinator on Galderma's $6.3 billion share sale, marking the largest sponsor-backed block trade in history.
- Trading Revenue Growth: Jefferies' capital markets business posted $799.3 million in revenue, up 13.5% from last year, with equities trading revenue rising 14% to a record $600.8 million, highlighting a trend of investors adjusting portfolios amid market volatility.
See More
SpaceX's Historic IPO Drives Record 2Q Market Recovery
- Market Recovery: The IPO market rebounded quickly in Q2, with 48 companies going public and raising a record $104.9 billion, indicating a resurgence of market confidence.
- SpaceX's Major Deal: SpaceX raised $75 billion in its IPO, surpassing the total of all US IPOs from the previous two years combined, achieving a market cap of $1.7 trillion at listing, making it one of the largest public companies on US exchanges.
- Strong First Day Performance: SpaceX's stock rose 19% on its debut, alleviating concerns about an overly hot or cold opening, although aftermarket trading remained volatile.
- Large Deal Momentum: Even without SpaceX's deal, Q2 would have been the largest quarter for IPO proceeds since 2021, with nine other IPOs raising over $1 billion, showcasing the ongoing appeal of large transactions.
See More
X-Energy Reports Strong First Earnings as Public Company
- First Earnings Highlights: X-Energy reported $43 million in revenue and grant income in its first FQ1 2026 earnings release as a public company, indicating strong market demand and growth potential.
- Successful IPO Financing: The company raised approximately $1.1 billion through its IPO on the Nasdaq Global Select Market, providing ample funding for future R&D and market expansion, thereby enhancing its financial stability.
- Significant Regulatory Progress: X-Energy made strides in regulatory and commercialization efforts, achieving progress in the UK Generic Design Assessment process and obtaining environmental clearance from the US Nuclear Regulatory Commission for a Texas project, marking a crucial step towards commercializing its small modular reactor technology.
- Strengthened Supply Chain Collaborations: The company has established agreements with industrial partners like SGL Carbon and IHI Corporation, and is engaging in exploratory deployment discussions with US energy utilities in Kentucky and Pennsylvania, further solidifying its supply chain and deployment pipeline.
See More
CHWY, XE, and WIX Stocks Hit Annual Lows Amid Weak Outlook
- CHWY Stock Decline: Chewy Inc.'s shares fell to an annual low of $19.08, down over 56% from its yearly high, as management flagged increasing challenges in the consumer pet environment despite reporting revenue and earnings growth in Q1, leading to price target cuts from Wall Street analysts that impacted investor confidence.
- XE Faces Financial Pressure: X-energy Inc.'s stock dropped to $18, marking a new low since its public listing, as retail investors turned bearish amid financial, valuation, and execution concerns, despite raising over $1 billion in a record nuclear IPO in April, resulting in a more than 38% decline since debut.
- WIX Hits 52-Week Low: Wix.com shares slumped to $46.10, influenced by Wall Street analysts' concerns over its growth outlook amid AI pressures, and the company revised its 2026 revenue expectations downward following workforce reductions, prompting multiple firms to cut price targets.
- Analysts Lower Price Targets: Major firms like Morgan Stanley, BofA, and UBS have reduced price targets for CHWY and WIX, reflecting market concerns about future growth, although retail investors remain optimistic about the fundamentals of these companies, indicating a divergence in market sentiment.
See More
